Chicago, IL 的 精神分裂症 臨床試驗
21 項針對 精神分裂症 的研究正在 Chicago（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
招募中歡迎健康志工
- The University of Chicago, Chicago
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
招募中1 期
- Uptown Research Institute, Chicago
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
招募中3 期
- Local Institution - 0067, Chicago
- Pillar Clinical Research -Chicago, Chicago
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
招募中3 期
- Neurocrine Clinical Site, Chicago
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
招募中3 期
- Local Institution - 0175, Chicago
- EmVenio Research Center - Prime Healthcare, Chicago
A Study of Brenipatide in Adult Participants With Schizophrenia
招募中2 期
- Re:Cognition Health - Chicago, Chicago
52-week Open Label Safety-Tolerability Study
招募中3 期
- Pillar Clinical Research, Chicago
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
招募中3 期
- Local Institution - 0122, Chicago
- EmVenio Research Center - Prime Healthcare, Chicago
A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
招募中1 期
- Uptown Research Institute, Chicago
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
招募中2 期
- Clinical Site, Chicago
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
招募中3 期
- Alkermes Investigator Site, Chicago
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
招募中2 期
- Uptown Research Institute LLC, Chicago
- Pillar Clinical Research LLC, Chicago
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
招募中3 期
- Pillar Clinical Research, Chicago
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
招募中2 期
- Uptown Research Institute, Chicago
A Study to Evaluate the Effect of KarXT on Urological Safety
招募中4 期
- Uptown Research Institute, Chicago
- Pillar Clinical Research -Chicago, Chicago
CLOZAPINE Response in Biotype-1
招募中4 期
- University of Chicago, Chicago
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
招募中觀察性研究
- University of Chicago Medical Center, Chicago
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
招募中3 期
- Neurocrine Clinical Site, Chicago
Randomized Withdrawal Study in Patients With Schizophrenia
招募中3 期
- Vanda Investigational Site, Chicago
Study of ALTO-101 in Patients With Schizophrenia
招募中2 期
- Site 5056, Chicago
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
招募中3 期歡迎健康志工
- Reviva site, Chicago
其他城市的 精神分裂症 試驗
- Atlanta, GA22 項研究
- Little Rock, AR19 項研究
- Hollywood, FL15 項研究
- Boston, MA14 項研究
- Houston, TX13 項研究
- San Diego, CA13 項研究
- Hialeah, FL13 項研究
- New York City, NY13 項研究
- Austin, TX13 項研究
- Garden Grove, CA12 項研究
- Germantown, MD11 項研究
- Miami, FL10 項研究
Chicago 的其他研究
- 非小細胞肺癌61 項研究
- 乳癌58 項研究
- 癌症（所有類型）51 項研究
- 轉移性癌症45 項研究
- 前列腺癌45 項研究
- 肥胖症41 項研究
- 肺癌41 項研究
- 卵巢癌36 項研究
- 中風34 項研究
- 大腸直腸癌33 項研究
- 心臟衰竭31 項研究
- 過重28 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。